BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36807190)

  • 21. Successful treatment with temozolomide in an elderly woman with advanced pulmonary large-cell neuroendocrine carcinoma: A case report.
    Wei J; Dong XF; Hu ZL; Tang S; Lu YF
    Medicine (Baltimore); 2018 Dec; 97(51):e13318. PubMed ID: 30572435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
    Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
    J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double primary lung carcinoma consisting of large cell neuroendocrine carcinoma and squamous cell carcinoma: report of a case.
    Yamada Y; Iyoda A; Suzuki M; Mizobuchi T; Baba M; Hiroshima K; Ohwada H; Fujisawa T
    Ann Thorac Cardiovasc Surg; 2005 Dec; 11(6):397-400. PubMed ID: 16401989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.
    Le Treut J; Sault MC; Lena H; Souquet PJ; Vergnenegre A; Le Caer H; Berard H; Boffa S; Monnet I; Damotte D; Chouaid C
    Ann Oncol; 2013 Jun; 24(6):1548-52. PubMed ID: 23406729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).
    Kenmotsu H; Niho S; Ito T; Ishikawa Y; Noguchi M; Tada H; Sekine I; Watanabe S; Yoshimura M; Yamamoto N; Oshita F; Kubota K; Nagai K
    Lung Cancer; 2014 Jun; 84(3):254-8. PubMed ID: 24679951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of gastric large cell neuroendocrine carcinoma (LCNEC) for whom chemotherapy of CDDP+CPT-11 proved very effective].
    Kirii Y; Ichikawa C; Miyamoto M; Hata M; Miyairi J; Takagi H; Fukushima M; Ota H
    Gan To Kagaku Ryoho; 2010 May; 37(5):895-8. PubMed ID: 20495323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of large cell neuroendocrine carcinoma of the rectum].
    Muto M; Ichiki K; Muto M; Ishikawa C; Inoue M; Aoki T; Hashimoto M; Inaba S; Yamamoto M
    Nihon Shokakibyo Gakkai Zasshi; 2015 Apr; 112(4):683-9. PubMed ID: 25843456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma.
    Kozuki T; Fujimoto N; Ueoka H; Kiura K; Fujiwara K; Shiomi K; Mizobuchi K; Tabata M; Hamazaki S; Tanimoto M
    J Cancer Res Clin Oncol; 2005 Mar; 131(3):147-51. PubMed ID: 15538626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC.
    Ogawa H; Sakai Y; Nishio W; Fujibayashi Y; Nishikubo M; Nishioka Y; Tane S; Kitamura Y; Sudo T; Sakuma T; Yoshimura M
    Thorac Cancer; 2020 Sep; 11(9):2561-2569. PubMed ID: 32691982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological features, clinical presentations and prognostic factors of ovarian large cell neuroendocrine carcinoma: a case report and review of published literature.
    Yang X; Chen J; Dong R
    J Ovarian Res; 2019 Jul; 12(1):69. PubMed ID: 31345245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial.
    Christopoulos P; Engel-Riedel W; Grohé C; Kropf-Sanchen C; von Pawel J; Gütz S; Kollmeier J; Eberhardt W; Ukena D; Baum V; Nimmrich I; Sieder C; Schnabel PA; Serke M; Thomas M
    Ann Oncol; 2017 Aug; 28(8):1898-1902. PubMed ID: 28535181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary large-cell neuroendocrine carcinoma (LCNEC).
    Hage R; Seldenrijk K; de Bruin P; van Swieten H; van den Bosch J
    Eur J Cardiothorac Surg; 2003 Apr; 23(4):457-60. PubMed ID: 12694759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A Case of Oropharyngeal Large Cell Neuroendocrine Carcinoma].
    Kadowaki Y; Hirano T; Nomi N; Suzuki M
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Sep; 118(9):1143-9. PubMed ID: 26615665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple large cell neuroendocrine carcinomas in the rectum and descending colon presented with liver metastasis: A case report.
    Fukushima N; Furukawa K; Takano Y; Suzuki T; Yoshinobu M; Hanyu K; Kobayashi S
    Asian J Endosc Surg; 2022 Apr; 15(2):405-409. PubMed ID: 35001529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center.
    Popov P; Steindl A; Wolff L; Bergen ES; Eckert F; Frischer JM; Widhalm G; Fuereder T; Raderer M; Berghoff AS; Preusser M; Kiesewetter B
    Clin Exp Metastasis; 2024 Feb; 41(1):25-32. PubMed ID: 38064128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous regression of recurrent pulmonary large cell neuroendocrine carcinoma with alteration of PD-L1 expression after surgical resection: A case report.
    Hong G; Chung C; Park D; Lee SI; Lee JE; Kang DH
    Thorac Cancer; 2024 Jan; 15(3):266-270. PubMed ID: 38057657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.
    Watanabe M; Matsumura Y; Yamaguchi H; Mine H; Takagi H; Ozaki Y; Fukuhara M; Muto S; Okabe N; Shio Y; Suzuki H
    Thorac Cancer; 2022 Oct; 13(19):2817-2822. PubMed ID: 36064196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Large-cell neuroendocrine carcinoma of the lung - challenges of diagnosis and treatment].
    Zombori T; Juhász-Nagy G; Tiszlavicz L; Cserni G; Furák J; Szalontai K; Pálföldi R
    Orv Hetil; 2020 Feb; 161(8):313-319. PubMed ID: 32073294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.
    Eichhorn F; Dienemann H; Muley T; Warth A; Hoffmann H
    Ann Thorac Surg; 2015 Mar; 99(3):983-9. PubMed ID: 25596870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.